Marvell Falls 28.1% in a Week After Lumentum Deal and Higher Outlook
· 6 sources
Marvell Technology had a sharp weekly decline despite a higher revenue outlook, as its all-stock Lumentum acquisition raised questions, outlets report.
What happened
Marvell Technology shares dropped 28.1% over the week, according to The Globe and Mail. Pluang reports that Marvell and Western Digital had their worst weekly decline since 2001, even though both raised guidance.
Scanx.trade reports that Marvell lifted its two-year revenue outlook to $30 billion, citing AI demand. TradingKey links the pressure on the shares to an all-stock acquisition of Lumentum, which it says pushed the stock to near a seven-month low.
TradingKey also notes that the $110 support level is facing a test. Ad-hoc-news.de reports a 6.2% bounce and discusses whether the Lumentum deal can justify itself, as well as dilution concerns tied to the all-stock structure.
Context
In an all-stock acquisition, the buyer pays with newly issued shares, which can increase the number of shares outstanding and is often debated by investors as dilution.
Why it matters
The episode shows how a stronger revenue outlook can be weighed against concerns over the cost and structure of a large acquisition.
Stocks in this story
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
$141.20+5.73% vs. previous close ($133.55) · November 6
Fair value (ATLAS)
$74.59Fair range: $25.52 to $106.66The price ($141.20) is 89.3% above that figure.
Chance of a rise in 1 month
44%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $112.40 and $162.91; 9 in 10, between $80.89 and $226.38.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy